CME Group appoints Jack Tobin as CFO

• Tobin has over 35 years of financial experience, joining CME in 2002 and previously serving as finance director at the Chicago Board of Trade before its 2007 merger with CME
• The appointment is part of a broader leadership transition announced in June when longtime leader Terry Duffy stepped aside for Fitzpatrick to become CEO
• Matthew Render, who joined CME as deputy chief accounting officer in August, will succeed Tobin as chief accounting officer

CME Group Appoints Jack Tobin as CFO in Leadership Succession Plan

CME Group Inc. announced Wednesday that Jack Tobin will succeed Lynne Fitzpatrick as Chief Financial Officer, part of a broader executive transition at the derivatives exchange operator.

Key Appointments:

• Tobin, currently CME's Chief Accounting Officer since 2015, will become Deputy CFO in November before assuming the full CFO role in March 2027
• The transition coincides with Fitzpatrick's promotion to CEO, making her CME's first female chief executive
• Matthew Render, who joined as Deputy Chief Accounting Officer in August, will replace Tobin in his current position

Executive Background:

Tobin brings extensive financial expertise to the role, having joined CME in 2002 with over 35 years of industry experience. He previously served as Director of Finance at the Chicago Board of Trade (CBOT) and as a principal consultant at PricewaterhouseCoopers. CME merged with CBOT in 2007.

Market Context:

The leadership changes come as traditional derivatives exchanges face mounting competitive pressure from emerging alternatives, including perpetual futures ("perps") and rapidly growing prediction markets. This is driving CME and similar platforms to diversify beyond their core business offerings.

The CFO appointment follows CME's June announcement that longtime leader Terry Duffy would step down to make way for Fitzpatrick's CEO appointment, signaling a comprehensive executive succession strategy at one of the world's largest derivatives marketplace operators.

The phased transition timeline through March 2027 suggests a deliberate approach to ensuring continuity during this period of market evolution and competitive challenges.